Home › All Companies › BMRA › Quarterly Report

BIOMERICA INC (BMRA) — Quarterly Report

AI-Powered SEC Filing Analysis

← All BMRA filings
Latest Quarterly Report Filed: 2026-04-13

Key Insights

  • The company reported a significant increase in sales revenue concentrated among a few key customers in the Middle East, Asia, and Europe regions over the past year.
  • The company's cost of goods sold was highly concentrated with a few key vendors, indicating potential supply chain risks.
  • The company made notable investments in intangible assets such as marketing/distribution rights, purchased technology, and patents, suggesting a focus on product development and expansion.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-04-13. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Quarterly Report filings

Filed: 2026-01-14
  • The company reported a significant increase in sales revenue from key customers in Asia, North America, and the Middle East during the third quarter of 2025 compared to the prior year period.
  • The company's accounts receivable balances from its four key customers in Asia, North America, Europe, and the Middle East have grown substantially over the past year, indicating potential liquidity and working capital challenges.
  • The company's cost of goods sold is highly concentrated with one key vendor and two other vendors, exposing it to supplier concentration risk that could impact margins.
Sentiment: Neutral Significance: 6/10
View Original Filing →

Other reports for BIOMERICA INC

Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.